Taoping Inc. (NASDAQ:TAOP, the ", , Company", , or ", , Taoping", , )))) today announced the Company signed a three-year strategic cooperation agreement with ZhongShengShi Co., Ltd.
Gainers
Spero Therapeutics, Inc. (NASDAQ: SPRO) rose 105.6% to $1.69 in pre-market trading. GSK and Spero Therapeutics announced exclusive license agreement for late-stage antibiotic asset, Tebipenem HBr.
Gainers
Taoping (NASDAQ:TAOP) stock moved upwards by 12.4% to $0.68 during Wednesday's pre-market session. The company's market cap stands at $10.6 million.